about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicMolecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern AlaskaHost factors that contribute to recurrent staphylococcal skin infectionAsymptomatic carriage of sequence type 398, spa type t571 methicillin-susceptible Staphylococcus aureus in an urban jail: a newly emerging, transmissible pathogenic strainMethicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles?The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).Modeling the transmission of community-associated methicillin-resistant Staphylococcus aureus: a dynamic agent-based simulation.Diffusion of clindamycin-resistant and erythromycin-resistant methicillin-susceptible Staphylococcus aureus (MSSA), potential ST398, in United States Veterans Health Administration Hospitals, 2003-2014.Validation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases.A national survey of skin infections, care behaviors and MRSA knowledge in the United States.New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infectionsAssociation of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United StatesEpidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis.Two cases of necrotizing fasciitis due to Acinetobacter baumannii.M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detaineesImmune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality.Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008.Central venous catheter-related bacteremia caused by Kocuria kristinae: case report and review of the literature.High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department.Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors.USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus.Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing.Do citation trends reflect epidemiologic patterns? Assessing MRSA, emerging and re-emerging pathogens, 1963-2014.Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study.MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006.Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997.Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology.USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000-2013.Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection.Comparing pulsed-field gel electrophoresis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for panton-valentine leukocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus isIncreasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003-2008.Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence ratesIdentification of source and sink populations for the emergence and global spread of the East-Asia clone of community-associated MRSA.A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail.Decreasing Incidence of Skin and Soft Tissue Infections With a Seasonal Pattern at an Academic Medical Center, 2006-2014.Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.Fulminant hepatic failure attributed to infection with human herpesvirus 6 (HHV-6) in an immunocompetent woman: A case report and review of the literature.Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals.
P50
Q24614464-2063A417-0804-4D28-B46C-ABE2094F4BD3Q24645571-2D5463BA-31BF-488D-A959-2D604CBF313FQ27005777-A77EEE51-A6F9-47DD-AB7A-D2ACEA17F3B2Q28384910-732DB296-8EAE-4AA5-9D60-E1658306F381Q28741085-F0559781-E83F-4BD6-8C1D-587E0C834A17Q30525482-7B056500-633D-4BB6-9448-D1B786CB3F4DQ33727930-A16E437B-C421-4188-AF8C-905F5C30179DQ33768052-A807DD70-4DB6-4A29-8040-9DCF14972F2BQ33772318-6B0706A2-3429-4E68-A140-141DEF0F09E4Q34066390-62F22589-7BBE-43A6-BBE7-C85007363406Q34242777-57F5314F-0B42-4944-9C30-009086B22896Q34354252-0B6A659F-6CFE-4826-8106-523D65BAD538Q34487570-3295BB1A-0DA5-4586-9545-D029D7A5861FQ34542185-6996214C-D7B8-4C38-9748-7C848817CC4DQ34598764-098307E7-14A9-42DF-9468-5BBCB2279A7DQ34828532-594E0B8B-8732-419B-8DE6-4F92EA2503B6Q35035822-4A45F69F-02DD-4595-B122-783CF47E7646Q35088590-841E3327-4B38-4252-A863-7BDD28947D4CQ35154914-6B9125D8-A398-46A6-9949-88216940CCAEQ35248150-F1D63293-E609-425B-88B8-2FFC518DE84FQ35331205-99A1B917-72DA-45DE-8E08-531211BC9021Q35473688-42659710-3F66-4F52-BA10-6B5AD5D974BBQ35677495-A0621681-F3B5-45C6-A738-6BE7355EA95FQ35677499-FED82C8D-2F35-42F6-A2BF-5C43E620FD6BQ35821647-9E91CBDB-87A5-44F6-8A96-0619E0BFC852Q35822216-3309F2AB-6D7D-49D6-9A78-F47C8EA6C1E1Q35845890-F3850FB7-C2E6-4074-946E-527B11B28681Q35868739-7CE17C80-15DD-44A7-92DE-3FDB8C079D2FQ35948772-3DFA9DC5-DF0E-46AF-B21D-4399E01786FDQ36212072-E4DB6533-B5AD-4BBA-BF74-2DA9D49E2434Q36227374-F94060A4-B83E-4604-AD17-7CA80BE833F2Q36667616-F28B586B-7151-45EF-928C-79C7FD19A53EQ36928851-119A2167-A21E-4F0B-AEC9-2B17A1041E69Q36933410-67E7858B-D661-463F-82CC-DB36BDFA73C0Q37129438-F4403654-40D4-4FDD-9F4A-1E5670CA748AQ38420470-6DB02A9E-70AB-4981-9BCB-48A37754B122Q38602743-2EEEE437-C473-405F-8538-660D7C3582E4Q38653582-14DEFD9F-22C6-472F-B1B8-9AA7385096DDQ38690532-952C806A-728B-4F2F-BDF6-B85224E987E9Q39016476-1DF007B8-B36B-44DC-BF07-4457A17E1E95
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Michael David
@de
Michael Z David
@en
Michael Z David
@es
Michael Z David
@nl
type
label
Michael David
@de
Michael Z David
@en
Michael Z David
@es
Michael Z David
@nl
altLabel
Michael David
@en
prefLabel
Michael David
@de
Michael Z David
@en
Michael Z David
@es
Michael Z David
@nl
P227
P101
P106
P1153
36885214100
P21
P214
1424151535360102890003
P227
1149694203
P31
P496
0000-0002-1926-7800